Abstract

Heparan sulfate proteoglycan 2 (HSPG2) is an essential, highly conserved gene whose expression influences many developmental processes including the formation of the heart and brain. The gene is widely expressed throughout the musculoskeletal system including cartilage, bone marrow and skeletal muscle. The HSPG2 gene product, perlecan is a multifunctional proteoglycan that preserves the integrity of extracellular matrices, patrols tissue borders, and controls various signaling pathways affecting cellular phenotype. Given HSPG2’s expression pattern and its role in so many fundamental processes, it is not surprising that relatively few gene mutations have been identified in viable organisms. Mutations to the perlecan gene are rare, with effects ranging from a relatively mild condition to a more severe and perinatally lethal form. This review will summarize the important studies characterizing mutations and variants of HSPG2 and discuss how these genomic modifications affect expression, function and phenotype. Additionally, this review will describe the clinical findings of reported HSPG2 mutations and their observed phenotypes. Finally, the evolutionary aspects that link gene integrity to function are discussed, including key findings from both in vivo animal studies and in vitro systems. We also hope to facilitate discussion about perlecan/HSPG2 and its role in normal physiology, to explain how mutation can lead to pathology, and to point out how this information can suggest pathways for future mechanistic studies.

Highlights

  • The human gene heparan sulfate proteoglycan 2/Heparan sulfate proteoglycan 2 (HSPG2) encodes for the secreted molecule perlecan, which is deposited in all basement membranes including those underlying epithelial and endothelial cells

  • Mutations in HSPG2 are associated with two classes of human skeletal disorders, known as Schwartz-Jampel syndrome (SJS; OMIM #255800) and dyssegmental dysplasia, Silverman-Handmaker type (DDSH; OMIM #224410)

  • Mutations to the Trol gene modulate key signaling processes, and influence cell behavior through rearrangements of the territorial matrix. Such is the case seen during Drosophila hematopoiesis, where perlecan is expressed along the thin basement membrane surrounding the blood progenitors

Read more

Summary

Introduction

The human gene heparan sulfate proteoglycan 2/HSPG2 encodes for the secreted molecule perlecan, which is deposited in all basement membranes including those underlying epithelial and endothelial cells. It is found in matrices produced in muscle, cartilage, and bone marrow. Post-translational variations that impact functions include GAG composition (HS versus CS content), proteolytic processing, exemplified by the matrix metalloproteinase-7 cleavage of perlecan that alters the semaphorin pathway and cell clustering [40], Genes 2018, 9, x FOR PEER REVIEW and GAGase trimming (byREVIEW heparanase, chondroitinases, or the Sulfs). This study showed that even subtle changes to GAG structure can have profound effects on function

Representation of human heparansulfate sulfate proteoglycan proteoglycan 2 2
Conservation of HSPG2
Ig various
Conservation of HSPG2 amongcommon common animal
HSPG2 Variants and Homologues
Developmental Expression of Perlecan
HSPG2 Associated Skeletal Defects
Mechanisms Underlying Perlecan Developmental Defects
Conclusions
Methods
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call